BIO-key International, Inc.

https://www.bio-key.com/

BIO-key International, Inc. is a global provider of Identity and Access Management (IAM) and biometric authentication solutions. The company's core mission is to revolutionize authentication and cybersecurity by offering secure, convenient, and user-friendly authentication methods, aiming to move beyond traditional passwords and hardware tokens. Headquartered in Holmdel, New Jersey, USA, BIO-key focuses on empowering organizations with robust identity solutions.

BIO-key's product portfolio includes the PortalGuard IAM platform and PortalGuard IDaaS (Identity-as-a-Service), which provide single sign-on, multi-factor authentication, and self-service password reset capabilities. They also offer WEB-key for biometric civil and large-scale ID infrastructure, and the MobileAuth mobile authentication application. The company develops and markets related hardware, such as fingerprint scanners and FIDO-compliant devices. Their solutions, which emphasize biometric-centric, multi-factor authentication and Identity-Bound Biometrics (IBB), serve diverse market segments including commercial, government, education, financial services, healthcare, manufacturing, and retail.

Michael W. DePasquale serves as the Chairman and Chief Executive Officer of BIO-key International, a position he has held since January 2003. In recent corporate developments, BIO-key International, Inc. executed a 1-for-10 reverse stock split on April 30, 2026, to regain compliance with Nasdaq's minimum bid price requirement. The company also announced a strategic partnership with TD SYNNEX Public Sector (DLT Solutions) in March 2026, aimed at expanding its security solutions to U.S. federal, state, and local government agencies. BIO-key anticipates a 50% increase in first-half 2026 revenues, driven by growing software license momentum and hardware sales.

Latest updates

BIO-key Initiates Reverse Stock Split to Regain Nasdaq Compliance

Event summary

  • BIO-key International, Inc. (BKYI) announced a 1-for-10 reverse stock split, effective April 30, 2026.
  • Stockholders approved the reverse split proposal last week, enabling the Board to act.
  • The split will reduce the number of outstanding shares from approximately 10.9 million to roughly 1.1 million.
  • The move is intended to help BIO-key regain compliance with Nasdaq’s minimum bid price requirement.
  • CEO Michael DePasquale stated the split aims to support growth goals, including profitability in the first half of 2026.

The big picture

BIO-key's reverse stock split is a common, albeit often unwelcome, maneuver for companies facing delisting risk. It artificially inflates the share price, buying time to improve underlying business fundamentals. The move highlights the ongoing challenges faced by smaller, specialized cybersecurity firms in maintaining public market listings, particularly as they navigate competitive pressures and the need for consistent revenue growth.

What we're watching

Compliance Risk
The success of the reverse split in restoring Nasdaq compliance is contingent on a sustained increase in the stock price, which is not guaranteed and reflects underlying business performance.
Profitability
BIO-key's stated goal of achieving profitability in the first half of 2026 will be a key indicator of whether the reverse split is a temporary fix or a catalyst for genuine turnaround.
Investor Sentiment
The market's reaction to the reverse split will reveal whether investors view it as a necessary step toward recovery or a sign of deeper, unresolved issues.

BIO-key Faces Nasdaq Non-Compliance Notice Over Delayed Financial Filing

Event summary

  • BIO-key International, Inc. received a notification letter from Nasdaq for failing to timely file its Form 10-K for the year ended December 31, 2025.
  • The company is in violation of Nasdaq Listing Rule 5250(c)(1).
  • The non-compliance notice currently has no immediate effect on BIO-key’s stock listing or trading.
  • BIO-key expects to file the delayed Form 10-K next week, working with its auditors.

The big picture

BIO-key’s delayed financial filing highlights the increasing scrutiny placed on public companies’ adherence to reporting deadlines. While the immediate impact is limited, the incident underscores potential governance and operational challenges within the organization, particularly concerning financial controls and audit processes. This event could also reflect broader trends of increased regulatory oversight and investor demand for transparency in the technology sector.

What we're watching

Financial Health
The content of the delayed 10-K will be critical to assess the underlying reasons for the filing delay and any potential material weaknesses in BIO-key’s financial reporting processes.
Nasdaq Compliance
Nasdaq will likely monitor BIO-key closely to ensure timely filing of future reports, and further non-compliance could trigger more severe listing consequences.
Investor Confidence
The delayed filing and subsequent non-compliance notice will likely erode investor confidence, potentially impacting the company’s stock price and ability to raise capital.

BIO-key Sees Revenue Surge, Eyes Larger Contracts Amidst Security Demand

Event summary

  • BIO-key anticipates 50% revenue growth in 1H’26, reaching approximately $5 million, compared to $3.3 million in 1H’25.
  • The company expects to achieve positive net income in 1H’26, reversing a $1.9 million net loss in 1H’25.
  • Key drivers include a $1.04 million software license renewal with a foreign retail bank and over $1 million in contracts for Pocket 10 Finger Scanners and Mobile POS Pro devices.
  • BIO-key is pursuing larger opportunities, including deployments with a foreign tax agency and a foreign defense ministry.

The big picture

BIO-key's strong first-half outlook reflects the growing demand for robust identity and access management solutions, particularly in sectors prioritizing security and regulatory compliance. The company's focus on biometric authentication aligns with broader trends towards passwordless authentication and enhanced cybersecurity measures. The success of these larger contract opportunities will be a key determinant of BIO-key's ability to transition from a loss-making entity to a consistently profitable one.

What we're watching

Contract Risk
The reliance on a few large contracts, particularly with foreign entities, exposes BIO-key to geopolitical and regulatory risks that could impact future revenue streams.
Execution Risk
Successfully integrating and deploying solutions for the foreign tax agency and defense ministry will be critical to realizing the anticipated benefits and requires navigating complex procurement processes.
Margin Discipline
Maintaining the disciplined margin management highlighted by management will be essential to sustaining profitability as the company pursues larger contracts and scales operations.

BIO-key Swings to Profitability on Defense Contracts, EMEA Transition

Event summary

  • BIO-key reported $6.1M in revenue for 2025, a 12% decrease from $6.9M in 2024, primarily due to a contract renewal and EMEA transition.
  • The company ended 2025 with $2.7M in cash, a significant increase from $0.4M in 2024, and a book value of $7.6M.
  • Preliminary Q1 2026 revenue reached $2.2M, up 37% year-over-year and 80% quarter-over-quarter.
  • Military and defense revenue exceeded $2.2M over the last twelve months, driven by a new deployment in the Middle East and a $280k follow-on order.

The big picture

BIO-key's strategic shift away from Swivel Secure distribution in EMEA, while initially impacting revenue, is intended to improve margins and unlock growth potential. The company's focus on foreign government and defense customers, particularly in Europe and the Middle East, aligns with a broader trend of increased cybersecurity spending driven by geopolitical instability. The improved cash position provides BIO-key with the resources to execute its growth strategy, but achieving profitability remains a key challenge.

What we're watching

Defense Spending
The sustainability of the defense sector revenue growth hinges on continued geopolitical tensions and the execution of the Defense & Intelligence Cybersecurity Initiative.
EMEA Transition
The long-term impact of the shift to BIO-key branded solutions in EMEA will depend on rebuilding a partner pipeline and offsetting the lost license revenue.
Profitability
Whether BIO-key can achieve break-even results in early 2026 will be determined by continued cost management and the ability to scale revenue growth.

BIO-key Gains Public Sector Foothold via TD SYNNEX Distribution Deal

Event summary

  • BIO-key International has partnered with TD SYNNEX Public Sector (DLT Solutions) to distribute its identity and access management (IAM) solutions to U.S. government agencies.
  • The partnership leverages DLT’s existing contracts and distribution network to streamline procurement for agencies seeking Zero Trust and phishing-resistant MFA solutions.
  • BIO-key’s PortalGuard IAM platform and Passkey:YOU biometric solutions will be integrated into DLT’s portfolio.
  • The deal aims to address increasing mandates for Zero Trust architectures and phishing-resistant MFA within the public sector.

The big picture

The partnership reflects the growing pressure on U.S. government agencies to modernize their cybersecurity posture and adopt Zero Trust architectures. BIO-key, a smaller player in the broader IAM market, is strategically leveraging DLT’s extensive public sector distribution network to gain access to a significant, albeit complex, market. This move is a common tactic for smaller vendors seeking to scale within the government space, but success hinges on navigating the intricacies of public procurement and competing against established incumbents.

What we're watching

Adoption Rate
The speed at which government agencies adopt BIO-key's solutions through DLT's channels will be a key indicator of the partnership's success, given the complexities of public sector procurement.
Contract Vehicles
BIO-key’s ability to secure and expand its presence on relevant DLT contract vehicles will determine the breadth of its reach within the public sector.
Competitive Landscape
How BIO-key differentiates its offerings against established IAM providers already serving the public sector, particularly given DLT’s existing relationships, will be crucial for gaining market share.

BIO-key Secures $2M in Military Contracts Amid Geopolitical Escalation

Event summary

  • BIO-key International secured over $2 million in military and defense orders over the last 12 months.
  • A foreign defense ministry placed a $280,000 follow-on order, bringing total business from that customer to $1.14 million in the past year.
  • The company's Defense & Intelligence Cybersecurity Initiative, launched in mid-2025, has contributed to securing new defense agency customers.
  • BIO-key supports over 50,000 licensed users within this foreign defense ministry, with the platform designed to scale to millions.
  • Jim Sullivan is SVP of Strategy and Chief Legal Officer; Michael DePasquale is Chairman and CEO.

The big picture

BIO-key is capitalizing on a growing demand for robust authentication solutions within the defense and intelligence sectors, driven by rising geopolitical instability and increasingly sophisticated cyber threats. The company's focus on biometric authentication, which mitigates risks associated with traditional methods like tokens and passwords, positions it favorably within this niche market. The $2 million in orders represents a meaningful, albeit small, contribution to the company's overall revenue, highlighting the strategic importance of this vertical.

What we're watching

Geopolitical Risk
Continued escalation of geopolitical tensions in the Middle East and elsewhere will likely drive further demand for BIO-key’s biometric authentication solutions, but also introduces volatility in customer acquisition and project timelines.
Execution Risk
The success of BIO-key’s Defense & Intelligence Cybersecurity Initiative hinges on its ability to effectively target and secure new contracts within a highly competitive and scrutinized market.
Scalability
BIO-key’s ability to scale its platform to support millions of users, as claimed, will be critical to realizing the full potential of its Defense & Intelligence Cybersecurity Initiative and maintaining margins.

BIO-key Secures $1.04M Renewal from Foreign Retail Bank

Event summary

  • BIO-key International, Inc. secured a $1.04 million license renewal and expansion order from a foreign retail bank, a customer since 2015.
  • The renewal represents a 30% increase in value compared to the prior year.
  • The bank’s biometric enrollment has grown from 7 million clients in 2015 to over 30 million currently, managing over 300 million fingerprints.
  • BIO-key’s year-end cash position is $2.7 million, supporting internal growth plans.
  • Approximately 10,000 bank employees utilize BIO-key’s fingerprint technology for authentication.

The big picture

This renewal highlights the growing importance of biometric authentication in retail banking, driven by the need for enhanced security, fraud prevention, and streamlined customer interactions. The significant increase in value and client base demonstrates the solution's utility and BIO-key’s potential to capitalize on the broader trend of digital identity verification. The company's reliance on renewals for cash flow also underscores the importance of customer retention in a competitive market.

What we're watching

Growth Trajectory
The 5% projected client enrollment growth rate will be a key indicator of the bank's adoption and BIO-key's ability to expand within the existing account.
Cash Flow
BIO-key’s stated ability to fund growth internally hinges on continued renewal activity and receivables collections; any deviation from expectations could impact future investments.
Competitive Landscape
The increasing reliance on biometric authentication in banking suggests intensifying competition in the identity management space, and BIO-key’s ability to maintain its position will depend on innovation and pricing.

BIO-key Secures Mozambique Payments Infrastructure Contract

Event summary

  • BIO-key International, Inc. secured a multi-year agreement with Sociedade Interbancária de Moçambique (SIMO), Mozambique’s national payments network operator.
  • The agreement, in partnership with RunLevel, builds on a prior 2025 deployment for a National Bank.
  • BIO-key’s PortalGuard IAM platform, PIN:You tokenless authentication, and SSO capabilities will be integrated into SIMO’s infrastructure.
  • SIMO manages Mozambique’s unified electronic payments system, serving a population of 36.6 million.
  • This marks BIO-key’s 11th banking and financial sector customer globally.

The big picture

This contract highlights the growing need for robust identity security in emerging markets undergoing rapid digital financial transformation. Mozambique's reliance on a single national payments network creates a concentrated risk profile, making secure authentication paramount. BIO-key's win underscores the increasing demand for biometric-centric IAM solutions in regions prioritizing financial inclusion and regulatory compliance, though success hinges on effective local partnerships like the one with RunLevel.

What we're watching

Regional Expansion
RunLevel’s focus on Portuguese-speaking African countries suggests BIO-key may target similar deployments in other PALOP nations, creating a potential pipeline of opportunities but also increasing geographic risk.
Regulatory Scrutiny
As Mozambique’s financial sector modernizes, SIMO’s adoption of enterprise-grade security will likely draw increased regulatory scrutiny, potentially requiring BIO-key to demonstrate ongoing compliance and adaptation.
Integration Complexity
The successful integration of BIO-key’s platform with SIMO’s existing infrastructure and the broader SIMOrede network will be critical; delays or technical challenges could impact the project's timeline and BIO-key’s reputation.

BIO-key Expands India Footprint Amid EU-India Trade Pact

Event summary

  • BIO-key International’s EMEA subsidiary is establishing a physical presence in Mumbai, India, its first in the country.
  • The expansion is being facilitated through a partnership with Citadel Global, a value-added distributor specializing in cybersecurity and identity solutions.
  • The initiative is directly linked to the recently signed EU-India free trade agreement, which aims to reduce tariffs and deepen economic cooperation.
  • BIO-key EMEA will offer its suite of IAM and biometric authentication solutions, including PortalGuard, Passkey:YOU, and Identity-Bound Biometrics, through Citadel’s local infrastructure.

The big picture

BIO-key's move signals a broader trend of Western technology firms capitalizing on the EU-India free trade agreement to gain access to a rapidly growing market. The agreement, touted as the largest trade pact ever, represents a significant opportunity for technology exports, but also introduces geopolitical considerations and increased competition. BIO-key’s success hinges on navigating the complexities of the Indian market and leveraging Citadel Global’s local expertise.

What we're watching

Trade Impact
The actual tariff reductions and trade volume increases resulting from the EU-India agreement will determine the true scope of opportunity for BIO-key and its competitors.
Partner Risk
Citadel Global's existing customer base and ability to effectively deploy and support BIO-key’s solutions will be critical to the success of this expansion, and any missteps could hinder adoption.
Competitive Landscape
The entry of BIO-key into the Indian market will likely intensify competition among IAM and biometric authentication providers, potentially impacting pricing and market share.

BIO-key Secures Portuguese Municipal Contracts via Visualforma Partnership

Event summary

  • BIO-key International, Inc. partnered with Visualforma, a Portuguese technology integrator, to secure digital identities for Portuguese municipal councils.
  • The contract focuses on deploying BIO-key’s IAM and biometric authentication technologies across over 250 Portuguese government organizations.
  • The initial rollout includes a major tourist city where the solution is already operational, supporting high-volume digital services.
  • BIO-key has already deployed its full IAM and biometric security portfolio in selected municipal environments, serving as reference architectures.

The big picture

BIO-key’s partnership with Visualforma represents a strategic move to penetrate the growing market for digital identity and access management within the European public sector. The Portuguese government’s push for digital transformation and increased cybersecurity creates a significant opportunity for BIO-key, but the reliance on a local integrator introduces execution risk. This contract underscores the increasing demand for biometric authentication solutions in government settings, driven by the need for enhanced security and citizen-centric services.

What we're watching

Execution Risk
The success of this partnership hinges on Visualforma’s ability to effectively deploy and integrate BIO-key’s solutions across a large and diverse network of Portuguese municipalities, potentially facing logistical and bureaucratic hurdles.
Regulatory Headwinds
Future expansion may be contingent on evolving eIDAS compliance requirements and potential shifts in Portuguese government procurement policies, impacting the scalability of BIO-key’s offerings.
Competitive Landscape
BIO-key’s market share in the Portuguese public sector will depend on its ability to differentiate its biometric-centric IAM solutions from competing offerings, particularly from larger, more established cybersecurity vendors.

BIO-key to Pitch Investors at DealFlow Conference Amid Authentication Market Growth

Event summary

  • BIO-key International (BKYI) will present at the DealFlow Discovery Conference in Atlantic City, NJ, January 28-29, 2025.
  • CEO Mike DePasquale will lead the presentation and be available for one-on-one investor meetings.
  • The DealFlow Discovery Conference, formerly The Microcap Conference, caters to institutional investors, family offices, and high-net-worth individuals.
  • BIO-key’s PortalGuard IAM solution secures access for over 40 million users.

The big picture

BIO-key operates in the rapidly expanding Identity and Access Management (IAM) market, driven by increasing cybersecurity threats and a shift towards passwordless authentication. The DealFlow Discovery Conference represents a strategic effort to attract institutional investment and broaden its investor base. The company’s success hinges on its ability to demonstrate a clear path to profitability and sustainable growth within a crowded and competitive market.

What we're watching

Investor Reception
The conference presentation and subsequent meetings will reveal the level of investor interest in BIO-key’s growth strategy and valuation, particularly given the competitive landscape in the authentication space.
Market Adoption
The pace at which BIO-key can expand its user base beyond the current 40 million will be critical for sustaining revenue growth and justifying its market capitalization.
Competitive Pressure
How BIO-key differentiates its offerings from larger, better-capitalized competitors in the passwordless authentication market will determine its ability to maintain market share and pricing power.
CID: 520